Optitren Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a dietary supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analog of essential amino acids, designed to provide the necessary substrates for protein synthesis while minimizing nitrogen intake. This mechanism helps reduce the accumulation of nitrogenous waste products, thereby alleviating the metabolic burden on impaired renal function. Optitren is indicated for patients with CKD who are on a restricted protein diet to delay the progression of renal failure and reduce uremic symptoms. The tablet is typically administered under medical supervision alongside a carefully controlled low-protein diet. Clinical use of Alpha Ketoanalogue has demonstrated benefits in maintaining nutritional status, preventing muscle wasting, and improving overall metabolic balance in CKD patients. It is important to adhere to prescribed dosages and dietary recommendations to optimize therapeutic outcomes. Contraindications include hypersensitivity to any component of the tablet and use in patients without renal impairment. Common adverse effects are rare but may include gastrointestinal discomfort. Optitren Tablet should be stored in a cool, dry place, away from direct sunlight, and kept out of reach of children. Consultation with a healthcare professional is essential before initiating therapy.